Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

Yanis Boumber

doi:10.21037/jtd.2018.07.120

Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

Yanis Boumber^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

51 Scopus citations

Original language	English (US)
Pages (from-to)	4689-4693
Number of pages	5
Journal	Journal of Thoracic Disease
Volume	10
Issue number	8
DOIs	https://doi.org/10.21037/jtd.2018.07.120
State	Published - 2018
Externally published	Yes

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.21037/jtd.2018.07.120

Cite this

@article{527def1afae7453e82545c81a490ab04,

title = "Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer",

author = "Yanis Boumber",

note = "Funding Information: The author thanks Galina Semenova, MD, PhD of Fox Chase Cancer Center for helping generate Figure 1. Funding: The author is supported by the NIH R01 CA218802 grant, NIH R21 CA223394 grant, Fox Chase Cancer Center Clinical Protocol Development Award, the Russian Foundation for Basic Research Grant 18-44-160004, and in part by the NCI Core Grant P30 CA006927 to Fox Chase Cancer Center.",

year = "2018",

doi = "10.21037/jtd.2018.07.120",

language = "English (US)",

volume = "10",

pages = "4689--4693",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "Pioneer Bioscience Publishing Company (PBPC)",

number = "8",

}

TY - JOUR

T1 - Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

AU - Boumber, Yanis

N1 - Funding Information: The author thanks Galina Semenova, MD, PhD of Fox Chase Cancer Center for helping generate Figure 1. Funding: The author is supported by the NIH R01 CA218802 grant, NIH R21 CA223394 grant, Fox Chase Cancer Center Clinical Protocol Development Award, the Russian Foundation for Basic Research Grant 18-44-160004, and in part by the NCI Core Grant P30 CA006927 to Fox Chase Cancer Center.

PY - 2018

Y1 - 2018

UR - http://www.scopus.com/inward/record.url?scp=85055622318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055622318&partnerID=8YFLogxK

U2 - 10.21037/jtd.2018.07.120

DO - 10.21037/jtd.2018.07.120

M3 - Review article

C2 - 30233840

AN - SCOPUS:85055622318

SN - 2072-1439

VL - 10

SP - 4689

EP - 4693

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 8

ER -

Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this